Malvina Lada
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection.
Journal: Cell reports. Medicine
Published: March 30, 2025
Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial.
Journal: International journal of antimicrobial agents
Published: November 03, 2024
Candida auris in Greek healthcare facilities: Active surveillance results on first cases and outbreaks from eleven hospitals within Attica region.
Journal: Journal de mycologie medicale
Published: August 01, 2023
Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial.
Journal: Critical care (London, England)
Published: March 30, 2022
Dating the Origin and Estimating the Transmission Rates of the Major HIV-1 Clusters in Greece: Evidence about the Earliest Subtype A1 Epidemic in Europe.
Journal: Viruses
Published: October 28, 2021
Using Machine Learning to Predict Antimicrobial Resistance of Acinetobacter Baumannii, Klebsiella Pneumoniae and Pseudomonas Aeruginosa Strains.
Journal: Studies in health technology and informatics
Published: May 27, 2021
Machine Learning for Antibiotic Resistance Prediction: A Prototype Using Off-the-Shelf Techniques and Entry-Level Data to Guide Empiric Antimicrobial Therapy.
Journal: Healthcare informatics research
Published: April 07, 2021
Soluble fms-like tyrosine kinase 1, placental growth factor and procalcitonin as biomarkers of gram-negative sepsis: Analysis through a derivation and a validation cohort.
Journal: Medicine
Published: January 04, 2021
A Nationwide Study about the Dispersal Patterns of the Predominant HIV-1 Subtypes A1 and B in Greece: Inference of the Molecular Transmission Clusters.
Journal: Viruses
Published: September 20, 2020
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Journal: American journal of respiratory and critical care medicine
Published: August 08, 2020
Last Updated: 09/26/2026